ALMS 内幕交易
ALMS 的 SEC Form 4 内幕交易记录
总交易
61
买入
10
买入总额
$39.3M
卖出总额
$1.5M
| 信号 | 内幕人 | 职位 | 方向 | 股数 | 价格 | 金额 | 日期 | 信号原因 |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(50) | TANANBAUM JAMES B. | - | 买入 | 117,647 | $17.00 | $2.0M | 2026-01-08 | 董事买入, 大股东(>10%)买入 |
| ★★★★★(50) | TANANBAUM JAMES B. | - | 买入 | 294,117 | $17.00 | $5.0M | 2026-01-08 | 董事买入, 大股东(>10%)买入 |
| ★★★★★(40) | AKKARAJU SRINIVAS | - | 买入 | 588,235 | $17.00 | $10.0M | 2026-01-09 | 董事买入, 超大额买入(>$5M) |
| ★★★★★(35) | AKKARAJU SRINIVAS | - | 买入 | 273,291 | $10.63 | $2.9M | 2026-09-08 | 董事买入, 百万级买入 |
| ★★★★★(35) | AKKARAJU SRINIVAS | - | 买入 | 273,290 | $10.63 | $2.9M | 2026-09-08 | 董事买入, 百万级买入 |
| ★★★★★(35) | AKKARAJU SRINIVAS | - | 买入 | 220,070 | $11.17 | $2.5M | 2026-09-04 | 董事买入, 百万级买入 |
| ★★★★★(35) | FORESITE CAPITAL MANAGEMENT VI LLC | - | 买入 | 117,647 | $17.00 | $2.0M | 2026-01-08 | 大股东(>10%)买入, 百万级买入 |
| ★★★★★(35) | FORESITE LABS, LLC | - | 买入 | 117,647 | $17.00 | $2.0M | 2026-01-08 | 大股东(>10%)买入, 百万级买入 |
| ★★★★★(35) | FORESITE CAPITAL MANAGEMENT VI LLC | - | 买入 | 294,117 | $17.00 | $5.0M | 2026-01-08 | 大股东(>10%)买入, 百万级买入 |
| ★★★★★(35) | FORESITE LABS, LLC | - | 买入 | 294,117 | $17.00 | $5.0M | 2026-01-08 | 大股东(>10%)买入, 百万级买入 |
| ★★★★★(28) | SCHROER JOHN R. | Chief Financial Officer | 卖出 | 3,282 | $26.37 | $87K | 2026-08-03 | CFO卖出, 非10b5-1计划卖出 |
| ★★★★★(26) | PANGALI SANAM | Chief Legal Officer | 卖出 | 5,000 | $28.00 | $140K | 2026-07-06 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(25) | AKKARAJU SRINIVAS | - | 卖出 | 48,066 | $10.55 | $507K | 2026-09-08 | 董事卖出, 大额卖出(>$500K) |
| ★★★★★(25) | AKKARAJU SRINIVAS | - | 卖出 | 48,065 | $10.55 | $507K | 2026-09-08 | 董事卖出, 大额卖出(>$500K) |
| ★★★★★(18) | PANGALI SANAM | Chief Legal Officer | 卖出 | 1,364 | $26.37 | $36K | 2026-08-03 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | HARDIMAN ROY C. | Chief Business & Strategy Ofcr | 卖出 | 2,692 | $26.37 | $71K | 2026-08-03 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | DRAPPA JORN | Chief Medical Officer | 卖出 | 2,447 | $26.37 | $65K | 2026-08-03 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | BRADLEY MARK CHRISTOPHER | Chief Development Officer | 卖出 | 2,572 | $26.37 | $68K | 2026-08-03 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | GOLDSTEIN DAVID M | Chief Scientific Officer | 卖出 | 2,596 | $26.37 | $68K | 2026-08-03 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(0) | AKKARAJU SRINIVAS | - | 卖出 | 0 | $9.18 | - | 2026-09-04 | |
| ★★★★★(0) | HARDIMAN ROY C. | Chief Business & Strategy Ofcr | 卖出 | 0 | - | - | 2026-08-03 | |
| ★★★★★(0) | BRADLEY MARK CHRISTOPHER | Chief Development Officer | 卖出 | 0 | - | - | 2026-08-03 | |
| ★★★★★(0) | GOLDSTEIN DAVID M | Chief Scientific Officer | 卖出 | 0 | - | - | 2026-08-03 | |
| ★★★★★(0) | PANGALI SANAM | Chief Legal Officer | 卖出 | 5,000 | - | - | 2026-07-06 | |
| ★★★★★(0) | SRIVASTAVA SAPNA | - | 卖出 | 15,528 | - | - | 2026-06-30 | |
| ★★★★★(0) | AKKARAJU SRINIVAS | - | 卖出 | 0 | - | - | 2026-06-30 | |
| ★★★★★(0) | MACHADO PATRICK | - | 卖出 | 3,553 | - | - | 2026-06-30 | |
| ★★★★★(0) | SRIVASTAVA SAPNA | - | 卖出 | 3,553 | - | - | 2026-06-30 | |
| ★★★★★(0) | YAO ZHENGBIN | - | 卖出 | 3,553 | - | - | 2026-06-30 | |
| ★★★★★(0) | AKKARAJU SRINIVAS | - | 卖出 | 15,528 | - | - | 2026-06-30 | |
| ★★★★★(0) | AKKARAJU SRINIVAS | - | 卖出 | 3,553 | - | - | 2026-06-30 | |
| ★★★★★(0) | MACHADO PATRICK | - | 卖出 | 15,528 | - | - | 2026-06-30 | |
| ★★★★★(0) | MACHADO PATRICK | - | 卖出 | 0 | - | - | 2026-06-30 | |
| ★★★★★(0) | YAO ZHENGBIN | - | 卖出 | 15,528 | - | - | 2026-06-30 | |
| ★★★★★(0) | TETRAULT LYNN A. | - | 卖出 | 15,528 | - | - | 2026-06-30 | |
| ★★★★★(0) | TETRAULT LYNN A. | - | 卖出 | 3,553 | - | - | 2026-06-30 | |
| ★★★★★(0) | DRAPPA JORN | Chief Medical Officer | 卖出 | 11,317 | - | - | 2026-05-22 | |
| ★★★★★(0) | DRAPPA JORN | Chief Medical Officer | 卖出 | 15,535 | $5.06 | $79K | 2026-05-22 | |
| ★★★★★(0) | FORESITE LABS, LLC | - | 卖出 | 680,486 | - | - | 2026-04-01 | |
| ★★★★★(0) | TANANBAUM JAMES B. | - | 卖出 | 1,176,470 | - | - | 2026-04-01 | |
| ★★★★★(0) | FORESITE CAPITAL MANAGEMENT VI LLC | - | 卖出 | 1,176,470 | - | - | 2026-04-01 | |
| ★★★★★(0) | TANANBAUM JAMES B. | - | 卖出 | 0 | - | - | 2026-04-01 | |
| ★★★★★(0) | FORESITE CAPITAL MANAGEMENT VI LLC | - | 卖出 | 1,123,337 | - | - | 2026-04-01 | |
| ★★★★★(0) | FORESITE LABS, LLC | - | 卖出 | 1,123,337 | - | - | 2026-04-01 | |
| ★★★★★(0) | FORESITE CAPITAL MANAGEMENT VI LLC | - | 卖出 | 680,486 | - | - | 2026-04-01 | |
| ★★★★★(0) | FORESITE LABS, LLC | - | 卖出 | 1,176,470 | - | - | 2026-04-01 | |
| ★★★★★(0) | FORESITE LABS, LLC | - | 卖出 | 0 | - | - | 2026-04-01 | |
| ★★★★★(0) | TANANBAUM JAMES B. | - | 卖出 | 680,486 | - | - | 2026-04-01 | |
| ★★★★★(0) | TANANBAUM JAMES B. | - | 卖出 | 1,123,337 | - | - | 2026-04-01 | |
| ★★★★★(0) | FORESITE CAPITAL MANAGEMENT VI LLC | - | 卖出 | 0 | - | - | 2026-04-01 | |
| ★★★★★(0) | BABLER MARTIN | President, CEO and Chairman | 卖出 | 745,875 | - | - | 2026-01-26 | |
| ★★★★★(0) | GOLDSTEIN DAVID M | Chief Scientific Officer | 卖出 | 216,675 | - | - | 2026-01-26 | |
| ★★★★★(0) | BRADLEY MARK CHRISTOPHER | Chief Development Officer | 卖出 | 190,225 | - | - | 2026-01-26 | |
| ★★★★★(0) | DRAPPA JORN | Chief Medical Officer | 卖出 | 221,450 | - | - | 2026-01-26 | |
| ★★★★★(0) | HARDIMAN ROY C. | Chief Business & Strategy Ofcr | 卖出 | 190,875 | - | - | 2026-01-26 | |
| ★★★★★(0) | SCHROER JOHN R. | Chief Financial Officer | 卖出 | 202,225 | - | - | 2026-01-26 | |
| ★★★★★(0) | PANGALI SANAM | Chief Legal Officer | 卖出 | 186,200 | - | - | 2026-01-26 | |
| ★★★★★(0) | AKKARAJU SRINIVAS | - | 卖出 | 0 | - | - | 2026-01-09 | |
| ★★★★★(0) | FORESITE LABS, LLC | - | 卖出 | 0 | - | - | 2026-01-08 | |
| ★★★★★(0) | FORESITE CAPITAL MANAGEMENT VI LLC | - | 卖出 | 0 | - | - | 2026-01-08 | |
| ★★★★★(0) | TANANBAUM JAMES B. | - | 卖出 | 0 | - | - | 2026-01-08 |